Loading...
Chemical structure of CLK-IN-T3

GC60716

CLK-IN-T3

Also known as 4-[2-methyl-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl]-N-(6-pyridin-4-ylimidazo[1,2-a]pyridin-2-yl)benzamide

CLK-IN-T3 is a high potent, selective, and stable CDC-like kinase (CLK) inhibitor with IC50s of 0·67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases, respectively· CLK-IN-T3 has anti-cancer activity

ChemicalCAS2109805-56-1MW482.58FormulaC28H30N6O2
CAS number
2109805-56-1
Molecular weight
482.58
Formula
C28H30N6O2
Solubility
DMSO： 4·83 mg/mL (10·01 mM)
InChIKey
IEFFSHLHNYVSEF-UHFFFAOYSA-N
Catalogue number
GC60716
Brand
GLPBIO
Computed properties PubChem CID 132585205 · XLogP 3.6 · TPSA 82.8 Ų · H-bond donors 1
XLogP
3.6
TPSA
82.8 Ų
H-bond donors
1
H-bond acceptors
5
Rotatable bonds
5
Heavy atoms
36

SMILES CC(C)(C1=CC=C(C=C1)C(=O)NC2=CN3C=C(C=CC3=N2)C4=CC=NC=C4)C(=O)N5CCN(CC5)C

Computed descriptors from PubChem (CID 132585205), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.